SERUM ENZYMES IN OVARIAN-CARCINOMA
- 1 January 1979
- journal article
- research article
- Vol. 26 (6) , 737-743
Abstract
The following enzymatic activities were measured in the serum of patients with benign and malignant ovarian tumors before treatment: alkaline and acid phosphatases, aspartyl (AspAT) and alanyl (AlAT) aminotransferases, leucyl (LAP) and alanyl (AAP) aminopeptidases, lactate dehydrogenase (LDH), .gamma.-glutamyl transpeptidase, cathepsin, alkaline ribonuclease (RNase), and .beta.-glucuronidase. At least 3 determinations (phosphatases and LAP) are practically useless in a discrimination between the examined groups. RNase in combination with AspAT (AlAT) or RNase with AAP and LDH give the best results as marker enzymes. [Diagnosis of ovarian cancer is discussed.].This publication has 7 references indexed in Scilit:
- CLINICAL SIGNIFICANCE OF AN INCREASED OR DECREASED SERUM ALKALINE-PHOSPHATASE LEVEL1978
- Serum glutamic oxalacetic transaminase/glutamic pyruvic transaminase ratios in hepatocellular carcinomaCancer, 1977
- Plasma ribonuclease.A marker for the detection of ovarian cancerCancer, 1977
- An assessment of the clinical usefulness of plasma ribonuclease assaysClinica Chimica Acta; International Journal of Clinical Chemistry, 1976
- Elevated serum ribonuclease in patients with pancreatic cancer.Proceedings of the National Academy of Sciences, 1976
- ISOLATION OF GAMMA-GLUTAMYL TRANSPEPTIDASE FROM HOG KIDNEY1965
- STUDIES ON THE GROSS STRUCTURE, CROSS-LINKAGES, AND TERMINAL SEQUENCES IN RIBONUCLEASEJournal of Biological Chemistry, 1954